| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 685039 | 74872 | IRBESARTAN VIATRIS 75 MG COMPRIMIDOS EFG | IRBESARTAN VIATRIS 75 MG COMPRIMIDOS EFG, 28 comprimidos | 75 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74872/74872_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74872/74872_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 2012-06-04 | 1 | 1 | 1 | 2012-06-04 | 2012-06-04 | 1 | 2013-08-13 | View Edit Delete | ||||||||||||
| 685053 | 74873 | IRBESARTAN VIATRIS 150 MG COMPRIMIDOS EFG | IRBESARTAN VIATRIS 150 MG COMPRIMIDOS EFG, 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74873/74873_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74873/74873_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 2012-06-04 | 1 | 1 | 1 | 2012-06-04 | 2012-06-04 | 1 | 2013-09-16 | View Edit Delete | ||||||||||||
| 685072 | 74874 | IRBESARTAN VIATRIS 300 MG COMPRIMIDOS EFG | IRBESARTAN VIATRIS 300 MG COMPRIMIDOS EFG, 28 comprimidos | 300 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74874/74874_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74874/74874_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 2012-06-04 | 1 | 1 | 1 | 2012-06-04 | 2012-06-04 | 1 | 2013-09-06 | View Edit Delete | ||||||||||||
| 684169 | 74726 | ACITRETINA IFC 25 mg CAPSULAS DURAS EFG | ACITRETINA IFC 25 mg CAPSULAS DURAS EFG , 30 cápsulas | 25 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74726/74726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74726/74726_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 39651 | INDUSTRIAL FARMACEUTICA CANTABRIA S.A. | 2011-11-30 | 1 | 1 | 1 | 2011-11-30 | 2011-11-30 | 1 | 2013-03-20 | View Edit Delete | ||||||||||||
| 684171 | 74727 | ACITRETINA IFC 10 mg CAPSULAS DURAS EFG | ACITRETINA IFC 10 mg CAPSULAS DURAS EFG , 30 cápsulas | 10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74727/74727_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74727/74727_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 39651 | INDUSTRIAL FARMACEUTICA CANTABRIA S.A. | 2011-11-30 | 1 | 1 | 1 | 2011-11-30 | 2011-11-30 | 1 | 2013-03-20 | View Edit Delete | ||||||||||||
| 681942 | 74376 | ZOLMITRIPTAN FLAS QUALIGEN 2,5 mg COMPRIMIDOS BUCODISPERSABLES EFG | ZOLMITRIPTAN FLAS QUALIGEN 2,5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 6 comprimidos | 2,5 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74376/74376_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74376/74376_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-07-08 | 1 | 1 | 1 | 2011-07-08 | 2011-07-08 | 1 | 2012-03-29 | View Edit Delete | ||||||||||||
| 681943 | 74377 | ZOLMITRIPTAN FLAS QUALIGEN 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | ZOLMITRIPTAN FLAS QUALIGEN 5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 6 comprimidos | 5 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74377/74377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74377/74377_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-07-08 | 1 | 1 | 1 | 2011-07-08 | 2011-07-08 | 1 | 2012-03-29 | View Edit Delete | ||||||||||||
| 685313 | 60735 | DONEKA PLUS 20/12.5 MG COMPRIMIDOS | DONEKA PLUS 20/12.5 MG COMPRIMIDOS , 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60735/60735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60735/60735_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 1995-07-01 | 1 | 1 | 1 | 1995-07-01 | 1995-07-01 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 685620 | 74982 | ACIDO IBANDRONICO QUALIGEN 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ACIDO IBANDRONICO QUALIGEN 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 1 comprimido | 150 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74982/74982_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74982/74982_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-11-15 | 1 | 1 | 1 | 2011-11-15 | 2011-11-15 | 1 | 2012-07-09 | View Edit Delete | ||||||||||||
| 686200 | 75102 | OLANZAPINA FLAS QUALIGEN 15 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 15 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75102/75102_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75102/75102_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-11-28 | 1 | 1 | 1 | 2011-11-28 | 2011-11-28 | 1 | 2012-03-13 | View Edit Delete | ||||||||||||
| 686201 | 75103 | OLANZAPINA FLAS QUALIGEN 20 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 20 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75103/75103_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75103/75103_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-11-28 | 1 | 1 | 1 | 2011-11-28 | 2011-11-28 | 1 | 2012-03-13 | View Edit Delete | ||||||||||||
| 681713 | 74332 | GALANTAMINA SANDOZ 8 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | GALANTAMINA SANDOZ 8 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 28 cápsulas | 8 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74332/74332_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74332/74332_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2012-02-24 | 1 | 1 | 1 | 2012-02-24 | 2012-02-24 | 1 | 2013-01-29 | View Edit Delete | ||||||||||||
| 681735 | 74333 | GALANTAMINA SANDOZ 16 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG. | GALANTAMINA SANDOZ 16 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG. , 28 cápsulas | 16 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74333/74333_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74333/74333_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2012-02-24 | 1 | 1 | 1 | 2012-02-24 | 2012-02-24 | 1 | 2013-01-29 | View Edit Delete | ||||||||||||
| 681755 | 74334 | GALANTAMINA SANDOZ 24 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | GALANTAMINA SANDOZ 24 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 28 cápsulas | 24 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74334/74334_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74334/74334_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2012-02-27 | 1 | 1 | 1 | 2012-02-27 | 2012-02-27 | 1 | 2013-01-29 | View Edit Delete | ||||||||||||
| 683123 | 74573 | MOXIFLOXACINO SANDOZ 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | MOXIFLOXACINO SANDOZ 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 5 comprimidos (PVC/PVDC-ALUMINIO) | 400 mg | 5 | 5 | 10 | 5 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74573/74573_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74573/74573_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2013-12-03 | 1 | 1 | 1 | 2014-04-29 | 2014-04-29 | 0 | 2014-06-04 | View Edit Delete | ||||||||||||
| 684160 | 74722 | RIZATRIPTAN SANDOZ 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | RIZATRIPTAN SANDOZ 10 mg COMPRIMIDOS BUCODISPERSABLES EFG , 2 comprimidos | 10 mg | 5 | 2 | 10 | 2 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74722/74722_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74722/74722_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2012-05-11 | 1 | 1 | 1 | 2013-07-12 | 2013-07-12 | 1 | 2013-08-09 | View Edit Delete | ||||||||||||
| 684162 | 74722 | RIZATRIPTAN SANDOZ 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | RIZATRIPTAN SANDOZ 10 mg COMPRIMIDOS BUCODISPERSABLES EFG , 6 comprimidos | 10 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74722/74722_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74722/74722_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2012-05-11 | 1 | 1 | 1 | 2013-07-12 | 2013-07-12 | 1 | 2013-08-09 | View Edit Delete | ||||||||||||
| 684939 | 74861 | DONEPEZILO FLAS SANDOZ 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | DONEPEZILO FLAS SANDOZ 5 mg COMPRIMIDOS BUCODISPERSABLES EFG , 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74861/74861_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74861/74861_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-12-16 | 1 | 1 | 1 | 2011-12-16 | 2011-12-16 | 1 | 2012-05-16 | View Edit Delete | ||||||||||||
| 684954 | 74862 | DONEPEZILO FLAS SANDOZ 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | DONEPEZILO FLAS SANDOZ 10 mg COMPRIMIDOS BUCODISPERSABLES EFG 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74862/74862_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74862/74862_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-12-16 | 1 | 1 | 1 | 2011-12-16 | 2011-12-16 | 1 | 2012-05-16 | View Edit Delete | ||||||||||||
| 685666 | 74988 | PERINDOPRIL/INDAPAMIDA VISO FARMACEUTICA 2 MG/0.625 MG COMPRIMIDOS EFG | PERINDOPRIL/INDAPAMIDA VISO FARMACEUTICA 2 MG/0.625 MG COMPRIMIDOS EFG , 30 comprimidos | 2 mg/0,625 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74988/74988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74988/74988_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2015-06-24 | 1 | 1 | 1 | 2015-06-24 | 2015-07-01 | 1 | 2016-05-26 | View Edit Delete |
Page 276 of 1035, showing 20 records out of 20689 total, starting on record 5501, ending on 5520